Á lódáil...
Unexpected favorable outcome to etoposide and cisplatin in a small cell lung cancer transformed patient: a case report
Patients with epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer can benefit significantly from EGFR tyrosine-kinase inhibitors (TKIs) treatment, but almost every patient will inevitably develop resistance. The transformation to small cell lung cancer (SCLC) has been described...
Na minha lista:
| Foilsithe in: | Cancer Biol Ther |
|---|---|
| Main Authors: | , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Taylor & Francis
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6741564/ https://ncbi.nlm.nih.gov/pubmed/31161851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2019.1617561 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|